SEC Form 4 · accession 0001144204-17-002438
Altimmune, Inc. · ALT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Derace L Schaffer
Director
Period of report
Jan 13, 2017
Accepted (ET)
Jan 17, 2017 · 4:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326190
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per share | Jan 13, 2017 | M | 20,000 | $2.20 | A | 1,043,782 | D | |
| Common Stock, $0.0001 par value per share | holding | — | — | — | 123,929 | I | IRA |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock option (right to buy) | $2.20 | Jan 13, 2017 | M | 20,000 | D | Jun 1, 2017 | May 31, 2026 | Common Stock | 20,000 | 0 | D |